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1. Introduction
The most important role of coronary angiography is to delineate coronary lesions that cause
inducible ischaemia. It remains the primary tool influencing the decision to undertake revas‐
cularization and patient outcomes [1] [2-4]. However, there are inherent limitations to diag‐
nostic angiography. These pitfalls include difficulties delineating eccentric plaque (that can
be underappreciated in the absence of multiple angiographic views), difficulty assessing le‐
sions of moderate severity, the assessment of overall plaque burden and the composition,
appreciation of ostial lesions, culprit lesion assessment in acute infarct patients and side
branch analysis in bifurcation lesions. Heavily calcified lesions can also produce hazy angio‐
graphic appearances which often leaves the operator at a loss to determine the actual true
lumen path and in some circumstances even misdiagnose calcification as “pseudothrom‐
bus” [5]. This latter phenomenon significantly changes the approach to intervention. The ar‐
tery can be put at risk of perforation in the absence of adequate lesion preparation or wire
induced dissection as calcified plaque is often undermined, complex and much more diffi‐
cult to wire than soft thrombus.
Furthermore, angiography is usually used in isolation to guide intervention and ensure an
adequate final stent result. FFR, IVUS and OCT can all be used to assess final PCI results
and stent performance over time.
To aid decision making processes, adjunctive tools are becoming essential in “getting it
right” in the catheterization laboratory. In this chapter, the use of FFR, IVUS and OCT for
assessing left main and non left-main coronary artery disease will be discussed.
© 2013 Incani et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
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2. An overview of FFR
Fractional Flow Reserve (FFR) is the ratio of two flows - maximal flow in the diseased vessel
expressed as a ratio to maximal flow if the vessel was theoretically normal[6]. During the
procedure, a 0.014 inch pressure sensor coronary guide wire is advanced beyond a coronary
stenosis and under conditions of maximal hyperaemia, distal pressure recorded and divided
by guiding catheter pressure. The procedure requires routine anticoagulation, a calibration
process [zeroing and equalization of the aortic (guiding catheter pressure Pa) with the pres‐
sure wire (Pd) and attainment of maximal hyperaemia (this is usually achieved by intrave‐
nous or intracoronary adenosine)[6]. FFR is a robust technique and reproducible which is
remarkable in that the microcirculation is able to vasodilate to the same degree each time
and is independent of heart rate and blood pressure [7,8]. It takes into account length of le‐
sion, lesion severity, amount of myocardium supplied, viability and contribution of collater‐
al blood flow [3,9,10]. It is now considered the gold standard for invasive functional
assessment of the physiological significance of coronary stenosis. |It has recently been given
a Class Ia indication for guiding PCI in multivessel coronary disease by the European Soci‐
ety of Cardiology [6].
2.1. Practicalities of FFR
Pressure Transducers: The current pressure transducers usually comprise a regular trans‐
ducer for aortic pressure (Pa) recorded through the guiding catheter and the second pres‐
sure (Pd beyond the stenosis) via a miniaturized sensor-tipped pressure wire that is
connected to a small computerized interface. Of note, a new wireless system is also about to
enter the commercial arena. Mean pressure recordings are essential as these form the nu‐
merator and denominator of the FFR formula, not peak systolic pressure. It is optional to re‐
cord Pv (central venous or right atrial pressure) via a central line if the operator wishes to
correct FFR for right atrial pressure – a concept that has been reborn in the modern FFR era
whereby filling pressures in cardiac failure patients may be significantly elevated and can
affect FFR recordings.
Medications: As is usual in any case where coronary wires are placed down coronary arter‐
ies, systemic anticoagulation (unfractionated heparin, low molecular weight heparin or bi‐
valirudin) is essential to avoid wire induced coronary thrombus. At our institution, the
usual practice is to administer heparin to achieve an ACT of at least 250 seconds. Intracoro‐
nary nitrate is then administered to overcome epicardial vessel vasospasm and for achieving
hyperaemia, either intracoronary or intravenous adenosine. Our preference is for intrave‐
nous adenosine via a femoral venous sheath, although all that is required is to achieve hy‐
peraemia – the route of administration is not as important. Intracoronary adenosine can also
be given, however, this is not suitable when there are side holes in the guiding catheter,
when ostial disease exists and when the aim of the study is to achieve a “pull-back” over the
course of a coronary artery. Alternative agents for achieving maximal hyperaemia include
intracoronary papaverine, intracoronary ATP, intravenous dipyridamole and intravenous
dobutamine, however these have not been as widely adopted.
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Catheters: In general, 5Fr or 6 Fr guiding catheters are used for performing FFR. This then
allows the operator to immediately go on to perform an intervention based on the FFR result
or indeed fix a wire induced dissection without needing to change catheters. The latter is a
rare phenomenon in experienced hands and with modern steerable soft tip pressure wires.
Larger French sizes are generally avoided on account of increased risk of catheter induced
ostial spasm and the possibility of reducing proximal coronary artery pressure.
Basic Formula for FFR:
FFR = Qs/Qn
Qs = flow in diseased artery and Qn = flow in artery if theoretically normal
Therefore: FFR = [Pd-Pv/R] / [Pa-Pv/R]
Pd = pressure distal to stenosis; Pa = aortic or guiding catheter pressure
Pv = venous or right atrial pressure
R = resistance
Given Pv is assumed to be negligible equal and at maximal hyperaemia R (resistance) is minimal then FFR = Pd/Pa
2.2. Summary for the sequence of events for performing FFR
1. Systemic Heparin to achieve ACT of at least 250 sec
2. Guiding Catheter sitting at ostium of coronary artery without damping
3. Zero guide and pressure wire
4. Remove wire introducer
5. Intracoronary GTN to overcome epicardial conduit resistance
6. Flush with saline
7. Equalize pressure wire and guiding catheter transducers
8. Cross stenosis with the pressure wire (N.B. the pressure sensor is at the junction of the
radiolucent and radio-opaque segments of the wire)
9. Run intravenous adenosine (our preferred method) to achieve maximal hyperaemia
10. Record FFR tracing with at least 2-3 min of adenosine
11. Remain vigilant for pressure signal drift and catheter damping
12. Pullback recording is reasonable across tandem stenoses or diffuse plaque
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Figure 1. Typical Example of FFR Recording (n.b. mean Pd and Pa pressures and automatic FFR recording as well as
transient bradycardia consistent with adenosine)
2.3. Pitfalls in FFR
Like most tools in coronary intervention, Fractional Flow Reserve is not immune to technical
mistakes [11]. It is important to be aware of the following various pitfalls to ensure that the
FFR measurement is both valid and reproducible.
a. Use of a guide wire introducer: when used through the Y connector, there is a subtle
leak of aortic guiding catheter pressure. Although it tends to only be small (<10mmHg),
when the FFR is near the ischemic zone, this small difference may have important im‐
plications. It is therefore recommended that when equalizing, measuring FFR and
checking for drift at the end of the procedure, that the wire introducer be removed.
b. Not clearing the catheter of contrast: ensuring that the guiding catheter is cleared of
contrast during equalization and FFR measurement is important to avoid subtle con‐
trast induced damping of pressure waveform. To overcome this, the guiding catheter
should be flushed with saline at the time of equalization and FFR measurement. It is im‐
portant to note ST changes at this time as over-enthusiastic flushing of the guiding cath‐
eter can lead to ischaemia induced ventricular fibrillation. It is advisable to flush in
stages giving the patient a break between 5-second flushes until the catheter is clear of
contrast on fluoroscopy.
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c. Damping of pressure by the guiding catheter: this is particularly true with diseased
ostia and when using large guiding catheters. It creates a gradient between the guiding
catheter and the proximal segment of the coronary artery and may only be unmasked
during maximal hyperaemia. It is important to monitor the Pa waveform at baseline
and during the FFR measurement and if indeed there is damping, the guiding catheter
needs to be “backed out” over the wire to ensure the Pa measurement is valid. This usu‐
ally necessitates the use of intravenous adenosine to maintain maximal hyperaemia
during the FFR recording. If guiding catheter damping is not appreciated, the obtained
FFR value will be artificially higher and the true severity of the stenosis underestimat‐
ed.
d. Guiding Catheter with Side Holes: it is technically obvious to avoid intracoronary ade‐
nosine in this setting however it is also important to always disengage the guide be‐
cause the side holes may actually confound true proximal coronary pressure
measurement. Therefore, if side holes are used, intravenous adenosine and a guiding
catheter sitting out of the ostium are imperative for an accurate FFR recording.
e. Signal Drift: High fidelity equipment make problems of signal drift less likely. Howev‐
er the problem can still occur. This issue is detected when an apparent gradient appears
between Pd and Pa without a change in waveform of the distal pressure. It should be
checked for at the end of the FFR procedure by ensuring that equalization still holds
true when the coronary wire is withdrawn back into the guiding catheter. This is an in‐
ternal check for the operator to ensure the final FFR reading is valid. In practical terms
however, a pullback curve will also overcome this limitation.
f. Maximal Hyperaemia: It cannot be emphasized enough that there is no such thing as a
resting FFR. It is only at maximal hyperaemia that resistance is minimal and that flow
develops a linear relationship to pressure – a vital prerequisite for the FFR equation to
hold true. Not achieving maximal hyperaemia will usually overestimate the FFR value
and therefore underestimate the true severity of a coronary stenosis. At the usual dose
of intravenous adenosine 140mcg/kg/min via a central sheath, all patients usually ach‐
ieve maximal hyperaemia within 2 minutes. Patients will often complain of chest tight‐
ness and dyspnoea and there will be a transient rise in blood pressure before the Pd
value reduces and adopts an ischaemic waveform with diastolic blunting. At this stage,
increasing the dose of adenosine will not alter the FFR value and the clinician will be
comfortable that maximal hyperaemia is achieved. It is not unusual for PR prolongation
or transient heart block to occur which can also be used as surrogate measures of maxi‐
mal hyperaemia [12].
3. An overview of IVUS
Intravascular ultrasound is a catheter based pullback technique that provides invasive cross-
sectional tomographic imaging [13,14]. The ultrasound signal is produced by sending an
electrical current through a crystal element on the transducer. Sound waves are reflected or
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pass through structures depending on their acoustic impedance. The scanning process pro‐
vides both a qualitative and quantitative assessment of the artery. Vessel wall, atherosclerot‐
ic burden and plaque composition can all be assessed and with a well defined lumen-intima
interface, measurements made of lesion severity such as minimum lumen area.
3.1. IVUS assessment of wall layers
The intima is a single layer of endothelial cells that is largely defined by its interface with
blood in the lumen [15]. Saline or contrast flush can help delineate this interface in complex
undermined plaque or when this interface may be ambiguous in cases such as lumen filling
defects or intramural haematoma.
The media is composed of smooth muscle cells and does not reflect ultrasound and there‐
fore appears as a dark ring during the pullback [15]. It is often used to help size stents along
with reference lumen dimensions.
The adventitia is a matrix of collagen and elastin and reflects ultrasound markedly to give a
whitish appearance on the outer segments of the vessel wall [15].
3.2. IVUS transducer type
There are two main types of transducers commercially available - a rotational single trans‐
ducer and multiple stationary transducers in a phased array system [16]. The following table
compares the current commercially available products.
Comparison Boston Scientific Volcano Volcano
Commercial Name iCross Eagle Eye Platinum Revolution
Imaging Method IVUS IVUS IVUS
Scanning Design Rotational Phased Array Rotational
Frequency 40 MHz 20 MHz 45 MHz
Overall Profile 3.2 Fr 3.5 Fr 3.2 Fr
Tip Entry Profile 0.022” 0.019”
Guide Catheter 6Fr 5Fr 6Fr
Delivery Monorail Rapid Exchange Monorail
Table 1.
The most commonly used device in our institution is the rotational system. There is a drive
cable that rotates a single transducer element at the tip. The imaging system is located with‐
in a protective sheath that is very soft and creates a fluid interface for the imaging transduc‐
er. The two main artifacts that are encountered include wire artifact and occasionally NURD
(Non-uniform Rotational Distortion) [16].
What Should We Know About Prevented, Diagnostic, and Interventional Therapy in Coronary Artery Disease262
Figure 2. Panel 1: Adventitia (A), Media (M), Intima (I) and Catheter (C), Panel 2: NURD (N), Panel 3: Wire Artifact, Pan‐
el 4: Eccentric fibrous plaque (P)
3.3. Plaque morphology by IVUS
Calcified Plaque has marked acoustic shadowing with signal drop out and appears white on
IVUS [15]. If circumferential calcification exists, this may prompt the operator to perform ro‐
tablation to ensure full stent expansion. Eccentric masses of bulky calcified plaque should
also alert the operator to the potential risk of vessel perforation during percutaneous coro‐
nary intervention (particularly if a cutting balloon is used or if aggressive postdilation is
performed) or focal stent under expansion. Generally, when only part of the vessel perime‐
ter is rigid, aggressive postdilation will force stent expansion into the direction of least re‐
sistance.
IVUS is also able to detect soft plaque, fibrous tissue and in-stent restenosis. Positive and
negative remodeling are also easily identified and generally best identified by IVUS.
Definition of diagnostic IVUS parameters for describing parameters of lesion significance as
per the “JACC IVUS Consensus Document” [17]:
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Term Description
Lumen Cross-Sectional Area (CSA) The area defined by the luminal border
Minimum Lumen Diameter (MLD) The shortest diameter through the centre point of the
lumen
Maximum Lumen Diameter The maximum diameter through the centre point of the
lumen
Lumen Eccentricity (Maximum lumen – MLD)/Maximum Lumen Diameter
Lumen Area Stenosis (Reference Lumen CSA – Minimum lumen CSA)/Reference
Lumen CSA
Lumen Diameter Stenosis (Reference Diameter – MLD)/Reference Diameter
Table 2.
Reference segments can be proximal and distal to the tightest point of the lesion and are
usually arbitrarily defined to be within 10 mm of the MLA at a point with the least disease
and not involving any side-branches.
Figure 3. Panel 1: 180 degree arc of calcium (C), Panel 2: Near 360 degree ring of calcium (C) – this would warrant rotablator,
Panel 3: Post Rota-PCI with full stent expansion (S), Panel 4: Plaque rupture (PR) – unstable plaque during ACS
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3.4. IVUS to guide intervention
Despite the relatively attractive ability to size stents and ensure adequate apposition and full
stent expansion, there is unfortunately a lack of evidence that IVUS improves the incidence
of MACE in patients undergoing stenting although 6-month angiographic diameters may be
improved (refer to table below). The exception to this however is in the left main interven‐
tional area whereby the use of IVUS improves outcomes [18].
Study Number (N) End Point Result
Albiero et al [19] 312 6mth angio IVUS better
Blasini et al [20] 212 6 mth angio IVUS better
Choi et al [21] 278 Acute closure; 6 month angio IVUS better
Gaster et al [22] 108 6 mth angio IVUS better
AVID [23] 759 12 mth TLR IVUS better
CRUISE [24] 499 9 mth TVR IVUS better
OPTICUS [25] 550 6 mth angio;
12mth MACE
NO DIFFERENCE
PRESTO [26] 9070 9 mth MACE NO DIFFERENCE
RESIST [27] 155 18mth MACE NO SIGNIFICANT DIFFERENCE
SIPS [28] 269 2 year TLR IVUS better
TULIP [29] 144 12 mth MACE IVUS better
Table 3. IVUS vs Angiographic Guidance of Bare Metal Stent Implantation
The use of IVUS in elucidating the mechanism of instent restenosis is also important particu‐
larly given that it may not be as benign as initially thought. Walters et al. have described
that an acute coronary syndrome is a common presentation for in-stent restenosis [30]. An‐
giography alone tends to overestimate the degree of restenosis and usually offers little infor‐
mation regarding the mechanism such as stent undersizing, incomplete expansion, strut
fracture and geographic miss. Now that we have arrived in the OCT era, we may gain fur‐
ther insights into neoatherosclerosis as apposed to proliferative fibrous neointima as the
pathology behind restenosis.
4. Overview of optical coherence tomography
OCT is an intravascular imaging modality akin to intravascular ultrasound (IVUS), howev‐
er, where IVUS uses sound, OCT uses light. The use of near infrared frequency (1300 nm)
light waves has remarkably increased resolution. OCT, unlike IVUS, requires a bloodless
field. This was originally achieved with proximal occlusion (i.e. time-domain OCT) but in its
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most recent iteration, has been achieved by contrast injection with Fourier Domain OCT.
This has significantly improved the user-friendliness of OCT. The characteristics of IVUS,
TD-OCT and FD-OCT are detailed below:
IVUS TD-OCT FD-OCT
Axial resolution, micron 100 10-15 10-15
Wavelength Ultrasound Near-infrared Near-infrared
Frame rate, frames/sec 30 20 100
Maximum scan diameter, mm 10 6.8 9.7
Proximal occlusion No Yes No
Pullback rate, mm/s 1 1-3 20
Table 4.
4.1. Procedural detail
The currently available OCT catheter is a rapid exchange catheter compatible with a 6Fr
guiding catheter. The OCT catheter has several markers and the position of the imaging op‐
tical lens is noted to be 25 mm from the tip of the catheter and 5 mm proximal to the proxi‐
mal marker. It appears as a radiolucent gap in the imaging catheter. It is thus important to
note that a considerable length of catheter is needed to be placed beyond a stenosis and
therefore a suitable landing zone is required that is of reasonable caliber and not excessively
tortuous. A calibration process is performed prior to image acquisition – z offset or auto-cal‐
ibration whereby marker fiducials are placed equidistant around the border of the catheter
on the computer interface. With an automated injection system, we advocate a contrast in‐
jection of 4mL/sec, 14mL volume for the left coronary system; 3mL/sec, 12 mL for the right
coronary system. For manual injection, usually 10mL contrast at reasonably sustained injec‐
tion pressure will be sufficient to opacify the vessel. Ischemic electrocardiographic changes
are not infrequent but almost always self-limiting; arrhythmia is rare and less frequent than
with TD-OCT. REF Other complications such as those from guiding catheters and coronary
wires are not attributable to OCT per se but are a part of the inherent risk of the procedure.
The main advantages with the FD-OCT over TD-OCT are the faster pullback speed (20mm/
sec) and the avoidance of proximal vessel occlusion, with potentially clearer images and
larger reference segment dimensions [31]. The safety and feasibility of FD-OCT has been
widely reported [32-34]. Slowing the pullback speed to 10 mm/sec can enhance the imaging
detail particularly if imaging for stent complications at the end of a PCI.
4.2. Current uses of OCT
Sine 1996, a lot of work has been performed evaluating the correlation of OCT with histopa‐
thology – an essential prerequisite to describing vessel pathology. Exquisite images and de‐
tailed analysis of plaque composition [35] can be achieved including clarification of lipid
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rich plaque, fibrous plaque, calcified nodules, macrophages, intimal disruption, red and
white thrombus and thin capped fibroatheroma. OCT has revolutionized the assessment of
stent performance with an unrivalled ability to detect malapposition, stent expansion, edge
dissection, prolapse, filling defects, strut appearance and strut coverage. It can even discrim‐
inate between neointima and neo-atherosclerosis with regard to in-stent restenosis and de‐
tect neorevascularisation. OCT is in its infancy in its ability to define flow-limiting stenoses
on the basis of lesion parameters for severity (akin to IVUS measurements).
Table 5.
Figure 4. Panel 1: Blood swirl artifact ; Panel 2: Wire artifact (W) ; Panel 3: Stitch artifact from catheter movement
(arrow) ; Panel 4: Spontaneous coronary dissection with visible false lumen (FL) ; Panel 5: Fibrous Plaque ; Panel 6:
Proliferative neointima within a stent
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Figure 5. Panel 1: Calcified Nodule (arrow); Panel 2: Red thrombus (arrow) ; Panel 3: Vasa Vasorum (arrow) ; Panel 4:
Covered stent – uncovered 7 years post deployment; Panel 5: Lipid rich plaque that is catheter hugging ; Panel 6: dis‐
rupted intima with a small cavity
4.3. Despite the overall attractiveness of OCT, some drawbacks include
• Need for extra contrast
• Limited ability to image very large vessels given limited depth of penetration (imaging
>4.5 mm diameter vessels is difficult)
• Difficulty to image true aorto-ostial disease (IVUS is preferred in this scenario)
• Blood pool artifact (this occurs when the lumen is not devoid of blood because of inade‐
quate contrast injection – the erythrocytes cause a severe scatter of light)
• Stitch artifact (usually only subtle and not a major issue; this artifact relates mostly to
catheter movement within the vessel and appears as an abrupt step in the vessel wall)
• If the catheter does not sit coaxially within the vessel then an oblique cut may be made
through the lumen and vessel wall
• Given the imaging catheter remains in the artery, there may be a tendency to straighten
the vessel, cause vessel concertina and perhaps even distort stents of questionable longi‐
tudinal strength
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• In the early phases of operator inexperience, there can be difficulty identifying calcium
and differentiating it from lipid rich plaque
5. Assessment of moderate coronary artery disease – Non Left Main
The presence of myocardial ischemia is an important determinant of adverse cardiac out‐
come [36,37]. Revascularization of stenotic coronary lesions, by eliminating myocardial is‐
chemia can improve patient symptoms, functional status and in patients with proven
ischaemia, reduce death and major adverse cardiovascular events [38-40]. Importantly, for
stenotic lesions that do not induce ischemia, medical therapy alone is likely to be equally ef‐
fective with less benefit for revascularization [2,3,40]. While most patients undergo non-in‐
vasive testing to detect the presence of myocardial ischemia prior to consideration of
angiography many patients with high clinical likelihood of CAD are catheterized without
functional testing. Additionally, noninvasive stress imaging studies may be non-diagnostic
and are limited in their ability to accurately localize culprit lesions in patients with multives‐
sel CAD [41]. Ultimately where revascularization is considered, patients undergo coronary
angiography.
Proving ischaemic burden in intermediate lesions requires invasive adjunctive tools – pres‐
sure derived measurements using FFR aim at functional evaluation whilst intravascular ul‐
trasound (IVUS) and OCT provide anatomical clarification of the vessel anatomy and lesion
dimensions. Both intracoronary IVUS and OCT can be used to measure lesion and vessel pa‐
rameters such as minimum luminal area and diameter. Unlike IVUS, OCT has only just be‐
gun to be validated against FFR. Given FFR is now the gold standard of invasive
physiological assessment of the stenosis functional significance, there are studies underway
to validate lesion parameters for severity on OCT with the physiological information ob‐
tained by FFR.
5.1. Coronary angiography and stenosis significance
Coronary angiography is a 2-dimensional lumenogram of a 3-dimensional vascular lumen.
It reports stenosis severity as a ratio of the lesion minimal lumen diameter to the adjacent
"normal" reference segment. But, coronary atherosclerosis is a diffuse process and the accu‐
racy of angiographic assessment is limited by the inability to identify both "diseased" and
"normal" vessel segments. Histopathological studies have demonstrated that angiography
fails to detect atheroma until the area stenosis approaches 40-50% as this is the approximate
critical level at which further expansion of the external elastic membrane is not possible and
so plaque begins to encroach upon the lumen. Furthermore, eccentric plaque produces an
eccentric lumen that can give conflicting degrees of angiographic narrowing dependant on
the viewing angulations. Despite improvements in quantitative coronary angiographic
(QCA) techniques, coronary angiography frequently fails to identify the accurate hemody‐
namic significance of coronary stenoses, particularly those between 30% and 70% diameter
stenosis [42-44]. The assessment and management of these “intermediate coronary lesions”,
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then becomes a dilemma for the clinician. In this context, a more reliable technique at the
time of angiography is vital to direct appropriate revascularization or medical therapy in a
single setting. Fractional flow reserve (FFR) assessment and Intravascular ultrasound (IVUS)
are two such techniques which are now part of standard clinical practice in guiding treat‐
ment of patients with intermediate coronary lesions [43,44] [45].
5.2. Fractional flow reserve and stenosis significance
Coronary pressure wire-derived FFR is now the technique of choice used in the cardiac cathe‐
terization laboratory to determine the functional significance of a coronary stenosis [45]. This
method relies on the decrease in intra-arterial pressure induced by a stenosis to determine
whether the lesion is producing physiologically significant ischemia. As described previously,
Fractional flow reserve (FFR) is defined as the ratio of flow in the stenotic artery to the flow in the
same artery in the theoretic absence of the stenosis [46]. Pressure is used as a surrogate of flow
and FFR can be calculated by measuring the pressure difference across a stenosis under maxi‐
mal hyperemia induced usually by adenosine. The pressure distal to the stenosis is accurately
measured by a 0.014-inch pressure sensor angioplasty guidewire passed distal to the stenosis.
FFR in a normal coronary artery = 1.0. FFR values of <0.75 (normal 1.0) are associated with posi‐
tive functional stress tests in numerous comparative studies [sensitivity (88%), specificity
(100%), positive predictive value (100%), and overall accuracy (93%)[45]. FFR values >0.80 are
associated with negative ischemic results with a predictive accuracy of 95% [45]. Deferring re‐
vascularisation based on non-significant FFR values (>0.75) are associated with rates of death or
myocardial infarction lower than that after routine stenting [3]. In patients with multivessel cor‐
onary artery disease FFR-guided PCI is associated with reduced major adverse cardiac events
[40]. Furthermore, De Bruyne et al have recently demonstrated that managing patients medical‐
ly (deferring PCI) with lesions that have documented ischaemic burden (defined as FFR < 0.80)
have an increased risk of urgent revascularisation [47].
Table 6.
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5.3. Fractional flow reserve corrected for right atrial pressure and stenosis significance
The original FFR calculation was derived from the following formula: FFR= (Pd-Pv)/(Pa-Pv)
where Pd is distal mean pressure, Pa is aortic/guiding catheter mean pressure and Pv is cen‐
tral venous/RA (right atrial) pressure [48,49]. Effectively, this is an FFR corrected for right
atrial pressure (FFRRA). FFRRA was used in some [49,50] but not all of the original validation
studies to determine which FFR values best predicts an ischaemic burden [51-53]. In all re‐
cent studies validating IVUS with FFR and FFR with revascularisation/outcomes, FFR was
never corrected for RA pressure. The simplified formula FFR = Pd/Pa was used largely
based on the assumption that Pv was minimal and therefore did not greatly influence the
final FFR result. Furthermore, previous data suggested that a correlation existed between
FFR and positron emmission tomography (PET) derived myocardial blood flow indices
even when RA pressure was ommitted [50]. However, this was a small series of low risk pa‐
tients with a mean RA pressure of 5 mmHg. This does not necessarily reflect the cohort of
patients coming through a high volume tertiary hospital with congestive cardiac failure pa‐
tients in which filling pressure may not be insignificant. This lead Layland et al to compare
FFRRA with FFR in assessing coronary stenoses in a real world cohort. They demonstrated
that right atrial pressure does in fact influence the FFR and tends to shift it downward into
the ischaemic threshold [54]. It is not known however, whether FFRRA (as opposed to FFR)
can be used to guide intervention or whether it would better correlate with IVUS or OCT
parameters for lesion severity.
5.4. Intravascular ultrasound (IVUS) and stenosis significance
As previously described, intravascular ultrasound is a catheter-based technique that pro‐
vides high-resolution (up to 150microns) cross-sectional tomographic images of the coro‐
nary lumen and the coronary arterial wall that can be visualized in real time. It is currently
the commonest intravascular imaging modality used as an adjunct to coronary angiography
and PCI. Intravascular ultrasound is simple to perform, and its use is associated with very
low complication rates [55]. IVUS does not provide direct hemodynamic data of a coronary
lesion. However, several studies have demonstrated a strong correlation between IVUS le‐
sion parameter and ischemia by myocardial perfusion imaging [56], and FFR [57,58]. Param‐
eters that correlated with an FFR value ≤0.75 were area stenosis (>60-70%), minimal lumen
cross-sectional area ≤3.0 - 4.0mm2 and minimal lumen diameter ≤1.8 mm. IVUS is used in
preference to FFR when:
1. Precise information on extent of the atherosclerosis, plaque characteristics including de‐
gree of calcification and accurate vessel size are required.
2. FFR assessment is contraindicated; significant conducting system disease or bradyar‐
rhythmia or severe asthma precluding the use of adenosine.
3. Situations where FFR values may be misleading; previous MI with significant scar, dif‐
fuse coronary disease, microvascular disease, significant left ventricular hypertrophy.
The traditional cutoff of MLA <4 mm2 on IVUS has been questioned in recent studies, and it
is now thought that an MLA of <2.4 mm2 may better predict a significant lesion [57-59]. Ulti‐
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mately, it is still unclear which of the two MLA cuttoff’s is more efficient in predicting sign‐
ficant stenoses, and future IVUS and OCT studies may also suffer from this “shifting
goalpost” phenomenon. This reflects the need for more studies validating anatomical with
physiological data.
In our catheterization laboratory about half of the stenosis assessments are done with IVUS.
In some centers’ it is the primary tool used [60]. There is a growing trend in our labarotory
now for using OCT instead of IVUS for plaque characterisation and vessel dimensions.
5.5. Optical coherence tomography and stenosis significance
Optical coherence tomography (OCT) is a recently introduced medical imaging technology.
It is an optical analogue of IVUS and measures the back-reflection of near-infrared light di‐
rected at tissues and generates images with a resolution close to 10micron; 10-15X greater
than IVUS. With the current generation of FD-OCT imaging engines, it is also up to 20 times
faster in imaging [35]. The safety of OCT imaging has been well described [61,62]. Given its
significantly higher resolution, OCT has many advantages over IVUS both in atherosclerotic
plaque assessment and in evaluating the acute and long-term effects of PCI [35]. It is likely
to replace IVUS as the primary intravascular imaging modality.
Table 7.
With its better definition of the intimal-luminal interface and higher resolution compared to
IVUS, OCT may improve accuracy and reduce observer variability in intravascular luminal
cross-sectional measurements; in this context OCT may be particularly useful in assessing (in‐
termediate) coronary stenosis severity. However, unlike IVUS which has many studies validat‐
ing it against FFR albeit with differing MLA results, there has only been one such trial using
OCT [59]. In this study, it was demonstrated that an MLA of 1.95 mm2 was most efficient at pre‐
dicting physiological significance. Gonzalo et al. [59] also demonstrated that OCT was more ef‐
ficient than IVUS in predicting stenosis severity and that the geometric cutoff values for both
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OCT and IVUS were indeed much smaller than the traditional 4 mm2. However, this study did
not correct FFR for right atrial pressure nor did it include OCT values indexed to the size of the
patient or reference vessel (in a bid to roughly adjust for mass of myocardium supplied) – two
corrections that may improve the correlation between OCT and FFR and affect the anatomical
parameter and its value that best predicts an FFR ≤0.80. Further studies are therefore a vital pre-
requisite before OCT can be validly used to establish stenosis significance.
In-vitro studies with a vascular phantom have shown that not only do OCT luminal meas‐
urements correlate strongly with IVUS but they are more accurate than IVUS [63]. Both in
vitro and in vivo studies suggest, however, that OCT measurements tend to be smaller than
IVUS measurements probably because of its better luminal definition [62,64]. Therefore, di‐
rect translation of IVUS parameters of stenosis significance to OCT is not appropriate or val‐
id. Specific in vivo validation data against FFR is required.
6. Other uses for FFR
FFR can be used to guide PCI formally to ensure full stent expansion based on FFR >0.94 [65] and
can also be used to evaluate side branch “pinching” post PCI. Koo et al demonstrated that when
the side branch was <75% stenosed post PCI, the FFR was never in the ischaemic range and
when it was >75% stenosed, it only fell into the ischaemic range approximately 1/3 of the time
[66]. This emphasizes a common issue of over-interpreting the side branch appearance in PCI
cases and vindicates bifurcation studies such as Nordic-Baltic Bifurcation Study III [67] where‐
by a simple approach to the side-branch is usually all that is required.
The use of FFR in vein grafts or in cases of severe left ventricular hypertrophy has not yet
been validated. Nor, is it a useful tool in the acute setting such as a STEMI when the micro‐
vasculature pressures are high and thereby the FFR falsely elevated [6].
The pressure sensor wire also has a temperature sensing function that enables it to detect
changes in temperature with saline flushes. Although beyond the scope of this chapter, it
has allowed the FFR wire to also measure microcirculatory function (Index of Microcircula‐
tory Resistance or IMR). The basic physiology behind IMR relates to transit time and tem‐
perature change detected by the wire sensor after flushing 3mls of saline via the guiding
catheter. Ultimately, transit time is inversely proportional to microcirculatory resistance
[68]. Although IMR is still largely a research tool, it has been shown to correlate with peak
CK enzyme rise post STEMI and therefore offers a proof of concept that microvascular ob‐
struction post ACS is detrimental [69].
7. Assessment of the ambiguous left main
7.1. Background
The accurate detection and description of disease of the left main coronary artery (LMCA) is
of fundamental importance in the evaluation of patients in the catheterization laboratory.
Improving the Utility of Coronary Angiography: The Use of Adjuvant Imaging and Physiological Assessment
http://dx.doi.org/10.5772/54041
273
Significant LMCA stenosis carries a poor prognosis without appropriate revascularization.
[70-72] Therefore, the presence or absence of left main disease has a critical impact on thera‐
peutic decision making following angiographic evaluation.
Angiographic assessment of the LMCA can be challenging. The anatomical plane of the
LMCA, issues with vessel overlap, elliptical vessel configuration and plaque eccentricity all
contribute to potential difficulty in accurately quantifying LMCA disease with conventional
coronary angiography alone. In cases where LMCA disease severity is ambiguous, indeter‐
minate or equivocal, adjunctive intravascular imaging or physiological assessment is of key
importance.[18]
Fractional flow reserve (FFR) offers a real time stress physiological assessment of coronary
pressure dynamics. Intravascular ultrasound (IVUS) is able to define the anatomy of the
LMCA. Both of these technologies allow for the potential to improve LMCA assessment and
attendant clinical outcomes and are discussed further below. Optical coherence tomography
(OCT) has a limited role in LMCA assessment, especially for ostial LMCA disease, largely
due to the dependence on having a contrast filled lumen to allow satisfactory imaging reso‐
lution to occur. [73]
7.2. Fractional flow reserve physiological assessment
FFR has been evaluated in several studies in the setting of LMCA disease. A cut off value for
the Pd/Pa (pressure distal/pressure aortic) ratio, following induction of hyperaemia, of <0.75
– 0.8 has been demonstrated to safely discriminate between patients who should be referred
for revascularization, usually coronary artery bypass grafting, as opposed to ongoing medi‐
cal therapy and observation. [74-81] Patients with readings between 0.75 – 0.8 have physiol‐
ogy in a range that requires further study. In patients with intermediate readings of this
kind the clinical context, as well consideration to additional evaluation with intravascular
ultrasound become important.
The FFR technique involves the placement of a high fidelity pressure sensor beyond the left
main plaque just as described in the “non left main” section previously. Consideration
should be given to performing the procedure in both the left anterior descending and left
circumflex artery to ensure concordance of results – this is particularly important if the cir‐
cumflex is dominant [18]. Once the wire is in position and the catheter flushed with 100 –
200 mcg of intracoronary nitroglycerine followed by saline, hyperaemia is induced with the
use of adenosine, 140 - 180 mcg/kg/min via intravenous infusion (central or peripheral).
Higher doses may be required if a systemic response is not demonstrated. Venous infusion
is preferred, however, adenosine can also be delivered by intracoronary bolus and studies in
the area suggest no major difference between the three administration methods, [82,83] al‐
though intracoronary bolus doses of up to 720 mcg on each injection may be required.[84]
There are several potential pitfalls to FFR evaluation of the left main. Of utmost importance
is the particular issue of guiding catheter damping and potential obstructive interference
with coronary flow. Disengagement of the guide catheter is required for accurate evaluation
in order to not underestimate the significance of the FFR. If a peripheral line is used for the
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adenosine infusion, care should be taken to ensure that the peripheral intravenous site is
flushing normally and appropriately connected. Maximal hyperaemia will be achieved in
most patients by two to three minutes, at which point the infusion can be ceased. An alterna‐
tive to the infusion of adenosine is intracoronary bolus injection, but this is potentially a less
robust [85] method and can be practically difficult if guide catheter pressure damping man‐
dates catheter disengagement. A further potential confounder is the role of right atrial pres‐
sure in FFR assessment. Although FFR adjusted for right atrial pressure was tested by
Layland et al in the non-left main subset, adjusting for assessment of left main has not been
conducted although a similar phenomenon would be expected – that being as FFR ap‐
proaches the ischaemic zone, right atrial pressure becomes increasingly important.[54] This
is an area that requires further investigation.
7.3. Intravascular ultrasound assessment
Intravascular ultrasound (IVUS) of the LMCA provides sonographically derived images of
the LMCA lumen and vessel wall. As a result, IVUS provides real time anatomical and
pathological information in 2 dimensions. IVUS parameters have been evaluated in multiple
studies in the setting of LMCA disease. Initial work that correlated IVUS data with clinical
outcomes demonstrated a relationship between IVUS derived minimal luminal diameter
(MLD) and minimal lumen area (MLA) at a lesion site with major adverse cardiovascular
events (MACE).[86] [87]These initial studies, however, did not mandate any specific cut off
values for treatment decisions. A clinical outcome based study by Fassa et al subsequently
demonstrated that deferral of revascularization is the appropriate strategy where the LMCA
MLA is ≥7.5 mm2. [88]More recent work has revised this measurement down to ≥6 mm2. [89]
Given the clinically validated findings for FFR, IVUS has also been investigated utilizing
FFR as a gold standard comparator. In a cohort of 51 North American patients Jasti et al
demonstrated that an MLD ≤2.8 mm2 or an MLA ≤5.9 mm2 correlated strongly with a FFR
<0.75. This study also correlated FFR measurements with clinical outcomes and confirmed
the appropriateness of an FFR cut off of <0.75. [90]Kang et al performed a similar correlation
study in 55 South Korean patients. They found a MLA cut off of <4.1 mm2 correlated well
with a FFR <0.75 and a MLA cut off of <4.8 mm2 correlated with a FFR of <0.8. However,
evaluation of clinical outcomes was not performed as was done in the study by Jasti et al. In
addition, the applicability of the study by Kang et al to patients of European ethnicity is un‐
clear. Both studies also demonstrated that relative disease burden metrics such as plaque
burden and area stenosis were insufficiently predictive of FFR measurements to be useful in
clinical practice.
Based on the above data, a cut off of ≤5.9 mm2 for MLA, if using IVUS alone, should be used
in determining referral for LMCA revascularization following IVUS evaluation. Where there
is uncertainty or ambiguity around measurements or their relevance in specific patients,
strong consideration should be given to adjunctive FFR evaluation.
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8. Case examples
Case #1: FFR and IVUS of Left Main
A 48 year-old gentleman presents with ischaemic sounding chest pain, troponin 1.3 ng/L
and subtle precordial ST depression on his ECG. He has a background history of smoking,
dyslipidaemia and a strong family history of premature coronary disease.
Angiography revealed an ambiguous left main with a complex hazy calcified roof. There
was an impression of severe ostial plaque with only a narrow jet of contrast effluxing back
into the left coronary cusp.
Figure 6. Angiographic (A and B) views and IVUS of left main (panels C and D)
The patient clearly had a left main lesion with an MLD < 2.8 mm and MLA < 5.9 mm2 and an
FFR <0.71 which was all consistent with a haemodynamically significant lesion. On the basis
of physiological and anatomical confirmation of severity, the patient was sent for CABG and
made an uneventful recovery. This case highlights the importance of careful inspection of
the angiogram in multiple views, consideration of the pitfalls of angiography and the com‐
bined use of IVUS and FFR to assess ambiguous left main plaque.
Case #2: FFR and OCT of a moderate RCA lesion:
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A 65 year old female presented with a long history of exertional chest discomfort and dysp‐
noea. A stress echocardiogram demonstrated possible mild exercise induced basal inferior
wall hypokinesia. She had a background history of severe uncontrolled hypertension. Her
left coronary tree was unremarkable. A 50% mid RCA lesion was interrogated by OCT and
FFR – refer to figures 8 and 9.
Given an MLA > 1.95mm2 on OCT and FFR > 0.80, the lesion was not stented. The recom‐
mendation was for improved blood pressure control. This case highlights the importance of
thorough assessment of moderate lesions despite a typical symptom profile of angina. This
patient almost certainly had hypertensive heart disease as a cause of her shortness of breath
and chest discomfort.
Case #3: Use of IVUS and OCT to diagnose spontaneous coronary dissection:
A 37 year-old female with a family history of coronary disease presents with chest pain, ele‐
vated biomarkers and ST praecordial T wave inversion on her 12 lead ECG a few months
postpartum.
Angiography revealed diffuse narrowing of distal left anterior descending artery (refer to
figure 10).
Figure 7. FFR of Left Main into LAD – dramatic drop in FFR to 0.71
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Figure 8. Panel A: Moderate RCA lesion with yellow line through the tightest point, Panel B: Proximal Reference Di‐
mensions, Panel C: Distal Reference Dimensions, Panel D: MLA and MLD
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Figure 9. FFR clearly not in the ischaemic zone
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Figure 10. Angiogram, IVUS and OCT of the mid to distal LAD, Panel A: Arrow points to abrupt change in vessel cali‐
ber, Panel B: IVUS with intramural haematoma (arrow), Panel C: OCT with intramural haematoma (arrow)
IVUS and OCT both confirmed spontaneous coronary dissection as the cause of the angio‐
graphic appearance with clear evidence of intramural haematoma. The patient was man‐
aged conservatively and made an uneventful recovery.
9. Concluding statement
This chapter has highlighted some of the most important points regarding FFR, OCT and
IVUS. In essence, these modalities are complimentary and it is up to the experienced opera‐
tor to decide on when one modality may have a clear advantage over another (e.g. IVUS be‐
ing more appropriate than OCT for imaging true aorto-ostial disease). It is generally
accepted that FFR is the most useful tool to help decide when to revascularise and
IVUS/OCT to help decide on pathology, guide the intervention and optimise the PCI result.
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